EVMS Home Secondary Page Menubar
About EVMS
Quick Facts
History
Centers of Excellence
EVMS News
Contact Us
Map of Eastern Virginia Medical Center
Driving Directions
About Hampton Roads
Teaching Hospitals
What's New?
Upcoming Events

EVMS Dean Appoints Two Veteran Faculty
To Lead Degree Programs

July 18, 2006

Timothy Bos, Ph.D.

Timothy Bos, Ph.D.

NORFOLK—EVMS Dean Gerald Pepe, Ph.D., has appointed veteran faculty to lead two degree programs. Timothy Bos, Ph.D., professor of microbiology and molecular biology, has been named director of biomedical sciences programs. David O. Matson, M.D., Ph.D., professor of pediatrics, has been named director of the EVMS Masters in Public Health program, a joint venture of EVMS and Old Dominion University.

The research-based programs under Bos include a doctoral and master’s track, which support EVMS research and funding.

“Dr. Bos’ leadership will help move the biomedical sciences Ph.D. program forward,” said Pepe.

As director of the program, Bos will continue to serve as a teacher and mentor to medical and graduate students. He also serves as director of the EVMS Microarray Core Facility.

Bos was instrumental in establishing a certificate program in biotechnology through a grant from the National Science Foundation.

A Virginia Beach resident, Bos joined EVMS in 1989. He received his Ph.D. in microbiology and immunology from the University of California at Los Angeles, School of Medicine.

David O. Matson, M.D., Ph.D.

David O. Matson, M.D., Ph.D.

Matson, former head of the infectious diseases section at the EVMS Center for Pediatric Research, has amassed a substantial body of research on viral enteritis.

“I’m looking forward to his leadership,” Dean Pepe said. “We’re fortunate to have someone of his caliber step up and take this on.”

In one of Matson’s most notable achievements, he served as principal U.S. investigator in one of the largest pre-licensure clinical trials in history, a study that included 71,000 children worldwide and demonstrated the safety and effectiveness of a vaccine for rotavirus, which kills 500,000 children in the developing world each year.

The results of that study, published in the New England Journal of Medicine, resulted in international publicity and FDA approval of the Merck vaccine Rotateq.

Matson, a Suffolk resident, received his M.D., and a Ph.D. in virology and epidemiology, at Baylor College of Medicine, where he also completed fellowships in molecular virology and pediatric infectious diseases.

Top

For more information, contact:

Doug Gardner, Director of News and Publications
EVMS Office of Institutional Advancement
(757) 446-6070 - gardneda@evms.edu

Home / Site Map / Search / About EVMS / Patient Services
Education / Research / Departments / Library

Feedback / Copyright © 1999-2006 Eastern Virginia Medical School
Revised: July 19, 2006